October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology
Apr 13, 2024, 09:52

Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology

Matt Campbell, Genitorurinary medical oncologist at UT MD Anderson Cancer center, shared a post on X:

HOT OFF THE PRESS: Happy to share the results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology from MD Anderson Cancer center.

Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology

Source: Matt Campbell/X